Please ensure Javascript is enabled for purposes of website accessibility

Why Zomedica Stock Soared Today and Then Plunged in After-Hours Trading

By Joe Tenebruso - Updated Feb 8, 2021 at 6:32PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The veterinary health specialist is cashing in on its recent gains.

What happened

Shares of Zomedica (ZOM -5.85%) surged 41% on Monday before pulling back after the market close.

So what 

Like many stocks that have caught the fancy of the increasingly popular WallStreetBets group on Reddit, Zomedica's share price has skyrocketed in recent weeks. At its closing price on Monday, the veterinary health company's stock was up a staggering 1,110% so far this year. 

A person is pointing to a digital stock chart that rises sharply and then falls.

Image source: Getty Images.

On Monday, Zomedica decided to take advantage of its torrid stock price to boost its cash reserves. The company said after the market close that it planned to raise roughly $25 million via the sale of nearly 13.2 million shares in a stock offering. 

Zomedica priced its shares at $1.90, or about 30% below its closing price of $2.70 on Monday, and its stock price fell in kind. As of 5:55 p.m. EST today, Zomedica's shares were down more than 10% in after-hours trading.

Now what 

Zomedica is gearing up for the upcoming launch of its Truforma diagnostic platform for dogs and cats, which is slated for March 30. Management is targeting a global pet diagnostics market that's projected to grow to $2.8 billion by 2024. Zomedica said that it will use the cash from its stock offering to fund the development of Truforma, as well as make milestone payments to its technology partners. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Zomedica Pharmaceuticals Corp. Stock Quote
Zomedica Pharmaceuticals Corp.
$0.22 (-5.85%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.